Literature DB >> 23730989

Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial.

Barry L Carter1, Christopher S Coffey, Liz Uribe, Paul A James, Brent M Egan, Gail Ardery, Elizabeth A Chrischilles, Dixie Ecklund, Mark Vander Weg, Thomas Vaughn.   

Abstract

This paper examines baseline characteristics from a prospective, cluster-randomized trial in 32 primary care offices. Offices were first stratified by percentage of minorities and level of clinical pharmacy services and then randomized into 1 of 3 study groups. The only differences between randomized arms were for marital status (P=.03) and type of insurance coverage (P<.001). Blood pressures (BPs) were similar in Caucasians and minority patients, primarily blacks, who were hypertensive at baseline. On multivariate analyses, patients who were 65 years and older had higher systolic BP (152.4 ± 14.3 mm Hg), but lower diastolic BP (77.3 ± 11.8 mm Hg) compared with those younger than 65 years (147.4 ± 15.0/88.6 ± 10.6 mm Hg, P<.001 for both systolic and diastolic BP). Other factors significantly associated with higher systolic BP were a longer duration of hypertension (P=.04) and lower basal metabolic index (P=.011). Patients with diabetes or chronic kidney disease had a lower systolic BP than those without these conditions (P<.0001). BP was similar across racial and socioeconomic groups for patients with uncontrolled hypertension in primary care, suggesting that patients with uncontrolled hypertension and an established primary care relationship likely have different reasons for poor BP control than other patient populations.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23730989      PMCID: PMC3683891          DOI: 10.1111/jch.12091

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs.

Authors:  S J Billups; D C Malone; B L Carter
Journal:  Pharmacotherapy       Date:  2000-08       Impact factor: 4.705

Review 2.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

3.  Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network.

Authors:  Denis Y Ishisaka; Trevor Jukes; Robert J Romanelli; Ken S Wong; Timothy A Schiro
Journal:  J Am Soc Hypertens       Date:  2012 May-Jun

4.  A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control.

Authors:  Barry L Carter; William Clarke; Gail Ardery; Cynthia A Weber; Paul A James; Mark Vander Weg; Elizabeth A Chrischilles; Thomas Vaughn; Brent M Egan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-07

5.  Evaluation of the technique used by health-care workers for taking blood pressure.

Authors:  I Villegas; I C Arias; A Botero; A Escobar
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

6.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers.

Authors:  D C Malone; B L Carter; S J Billups; R J Valuck; D J Barnette; C D Sintek; G J Okano; S Ellis; D Covey; B Mason; S Jue; J Carmichael; K Guthrie; L Sloboda; R Dombrowski; D R Geraets; M G Amato
Journal:  Pharmacotherapy       Date:  2000-10       Impact factor: 4.705

8.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

9.  Self-reported Morisky score for identifying nonadherence with cardiovascular medications.

Authors:  Stephen J Shalansky; Adrian R Levy; Andrew P Ignaszewski
Journal:  Ann Pharmacother       Date:  2004-07-06       Impact factor: 3.154

10.  Five-year blood pressure control and mortality following health education for hypertensive patients.

Authors:  D E Morisky; D M Levine; L W Green; S Shapiro; R P Russell; C R Smith
Journal:  Am J Public Health       Date:  1983-02       Impact factor: 9.308

View more
  9 in total

1.  Physician-pharmacist collaborative management of asthma in primary care.

Authors:  Tyler H Gums; Barry L Carter; Gary Milavetz; Lucinda Buys; Kurt Rosenkrans; Liz Uribe; Christopher Coffey; Eric J MacLaughlin; Rodney B Young; Adrienne Z Ables; Nima Patel-Shori; Angela Wisniewski
Journal:  Pharmacotherapy       Date:  2014-08-20       Impact factor: 4.705

2.  Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.

Authors:  Maxwell D Anderegg; Tyler H Gums; Liz Uribe; Christopher S Coffey; Paul A James; Barry L Carter
Journal:  Hypertension       Date:  2016-09-06       Impact factor: 10.190

3.  Pharmacist intervention for blood pressure control: medication intensification and adherence.

Authors:  Tyler H Gums; Liz Uribe; Mark W Vander Weg; Paul James; Christopher Coffey; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2015-05-15

4.  Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Authors:  Brian J Isetts; Daniel E Buffington; Barry L Carter; Marie Smith; Linnea A Polgreen; Paul A James
Journal:  Pharmacotherapy       Date:  2016-03-18       Impact factor: 4.705

Review 5.  Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care.

Authors:  Barry L Carter
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

6.  A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.

Authors:  Barry L Carter; Christopher S Coffey; Elizabeth A Chrischilles; Gail Ardery; Dixie Ecklund; Brian Gryzlak; Mark W Vander Weg; Paul A James; Alan J Christensen; Christopher P Parker; Tyler Gums; Rachel J Finkelstein; Liz Uribe; Linnea A Polgreen
Journal:  Pharmacotherapy       Date:  2015-06-25       Impact factor: 4.705

7.  Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.

Authors:  Barry L Carter; Christopher S Coffey; Gail Ardery; Liz Uribe; Dixie Ecklund; Paul James; Brent Egan; Mark Vander Weg; Elizabeth Chrischilles; Thomas Vaughn
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-03-24

Review 8.  Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.

Authors:  Barry L Carter; Gail Ardery
Journal:  J Am Heart Assoc       Date:  2016-12-19       Impact factor: 5.501

9.  Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT.

Authors:  Andi Shahu; Jeph Herrin; Sanket S Dhruva; Nihar R Desai; Barry R Davis; Harlan M Krumholz; Erica S Spatz
Journal:  J Am Heart Assoc       Date:  2019-07-31       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.